• home
  • about us
    • the advantage
    • key facts
    • where we are
    • where we invest
    • management team
    • funds
  • portfolio
    • companies
    • CEOs
  • news
  • investments
    • focus
      • prevention & nutraceuticals
      • medical foods OTC, Rx
      • enabling technologies
      • brands & channels
      • diagnostics
    • criteria
    • process
  • your business
  • careers
  • contact us
    • the bahamas
    • united kingdom
    • switzerland
    • new zealand

portfolio

Creatogen

Founded in 2003, as a spin-off from the Max Planck Institute for Infection Biology in Berlin (Germany) Creatogen develops bacterial carriers for oral delivery to treat and to prevent acute and chronic diseases caused by an imbalance of the immune system. Creatogen is in final development of a bird-flu vaccine for poultry.

www.creatogen.de
www.creatogen.de
Back to portfolio ...
Arvind Sridharan, Horizon
Arvind Sridharan, Horizon:
"Inventages has set itself high standards - and naturally expects the same from its portfolio companies." More...
Terms Print Top
© 2012 Inventages